# Grace Therapeutics, Inc.: Form 8-K, filed Oct 2, 2020

- Company: [Grace Therapeutics, Inc.](/companies/grce.md) (CIK 1444192)
- Form: 8-K
- Filed: 2020-10-02
- Accepted by EDGAR: Oct 2, 2020, 15:39 ET
- Period: 2020-09-30
- Accession: 0001171843-20-006824
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1444192/000117184320006824/f8k_100220.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1444192/000117184320006824/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1444192/000117184320006824/f8k_100220.htm

Filed Oct 2, 2020.
Source: SEC EDGAR, the filing index for accession 0001171843-20-006824. Last ingested by Listed: Nov 14, 2026, 23:10 ET. No prices; not investment advice.
